FormDSignal
35

Allotera Therapeutics, Inc. files Form D

Company raise update · Raising · ST. LOUIS, MO · Form D/A filed 2026-07-23
$50M+ raise

Why now — by persona

Relevant to: B2B software & services sales. Lead card pending.

People on the filing

Drew DennisonDirector
Kevin LiDirector
Natalie MountDirector
Niall O'DonnellDirector
Kumar SrinivasanExecutive Officer, Director
Matthew CooperExecutive Officer
Bosun HauDirector
Peter KienerDirector
Cherry ThomasExecutive Officer
Ayman KabakibiExecutive Officer
Bali MuralidharDirector

Signed by Kumar Srinivasan, President and Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer